Open access · CC-BY
via OpenAlex
Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study
Arnaud D. Kazé, Prasanna Santhanam, Solomon K. Musani, Rexford S. Ahima, Justin Basile Echouffo-Tcheugui
Journal of the American Heart Association · 2021 · ▲ 167 citations
Abstract
Background Metabolic dyslipidemia (high triglyceride) and low high‐density lipoprotein cholesterol (HDL‐C) is highly prevalent in type 2 diabetes mellitus (T2DM). The extent to which diabetes mellitus–related abnormalities in the triglyceride–HDL‐C profile associates with cardiovascular disease (CVD) risk is incompletely understood. We evaluated the associations of triglyceride and HDL‐C status with CVD outcomes in individuals with T2DM. Methods and Results We analyzed data from 4199 overweight/obese adults with T2DM free of CVD with available data on triglyceride and HDL‐C at baseline (2001–2004) in the Look AHEAD (Action for Health in Diabetes) study. We used Cox proportional models to estimate hazard ratios (HRs) and 95% CIs of: (1) composite CVD outcome (myocardial infarction, stroke, hospitalization for angina, and/or death from cardiovascular causes); (2) coronary artery disease events; and (3) cerebrovascular accidents (stroke). Of the 4199 participants, 62% (n=2600) were women, with a mean age of 58 years (SD, 7), and 40% (n=1659) had metabolic dyslipidemia at baseline. Over a median follow‐up of 9.5 years (interquartile range, 8.7–10.3), 500 participants experienced the composite CVD outcome, 396 experienced coronary artery disease events, and 100 experienced stroke. Low HDL‐C was associated with higher hazards of the composite CVD outcome (HR, 1.36; 95% CI, 1.12–1.64 [ P =0.002]) and coronary artery disease events (HR, 1.46; 95% CI, 1.18–1.81 [ P =0.001]) but not stroke (HR, 1.38; 95% CI, 0.90–2.11 [ P =0.140]). Compared with patients with normal triglyceride and normal HDL, participants with metabolic dyslipidemia had higher risks of the composite CVD outcome (HR, 1.30; 95% CI, 1.03–1.63 [ P =0.025]) and coronary artery disease events (HR, 1.48; 95% CI, 1.14–1.93 [ P =0.003]) but not stroke (HR, 1.23; 95% CI, 0.74–2.05 [ P =0.420]). Conclusions In a large sample of overweight/obese individuals with T2DM, metabolic dyslipidemia was associated with higher risks of CVD outcomes. Our findings highlight the necessity to account for metabolic dyslipidemia in CVD risk stratification among patients with T2DM. Registration URL: https://www.lookaheadtrial.org ; Unique identifier: NCT00017953 .
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1161/jaha.120.016947
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Kazé, A.D., Santhanam, P., Musani, S.K., Ahima, R.S., & Echouffo-Tcheugui, J.B. (2021). Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study. <em>Journal of the American Heart Association</em>. https://doi.org/10.1161/jaha.120.016947
Vancouver
Kazé AD, Santhanam P, Musani SK, Ahima RS, Echouffo-Tcheugui JB. Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study. Journal of the American Heart Association. 2021. doi:10.1161/jaha.120.016947.
BibTeX
@article{arnaud2021Metabo,
title = {Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study},
author = {Arnaud D. Kazé and Prasanna Santhanam and Solomon K. Musani and Rexford S. Ahima and Justin Basile Echouffo-Tcheugui},
journal = {Journal of the American Heart Association},
year = {2021},
doi = {10.1161/jaha.120.016947},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Diabetes Care 2008
Open access · CC-BY
Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome
Circulation 2005
Citation only
Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus
Diabetes Care 2010
Open access · CC-BY
Impact of BMI and the Metabolic Syndrome on the Risk of Diabetes in Middle-Aged Men
Clinical Chemistry 2007
Citation only
Plasma Uric Acid and the Risk of Type 2 Diabetes in a Chinese Community
The Journal of Clinical Endocrinology & Metabolism 2009
Open access · OA
Associations among Metabolic Syndrome, Ischemia, Inflammatory, Oxidatives, and Lipids Biomarkers
The Journal of Clinical Endocrinology & Metabolism 2006
Citation only